SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

ZAULI, Giorgio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.413
EU - Europa 5.592
AS - Asia 3.966
SA - Sud America 66
AF - Africa 19
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 7
Totale 31.080
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.320
CN - Cina 1.881
IT - Italia 1.325
UA - Ucraina 1.213
SG - Singapore 982
DE - Germania 849
TR - Turchia 783
PL - Polonia 735
GB - Regno Unito 573
FI - Finlandia 309
SE - Svezia 263
ID - Indonesia 139
CA - Canada 84
FR - Francia 68
VN - Vietnam 65
BE - Belgio 59
RU - Federazione Russa 58
BR - Brasile 55
CZ - Repubblica Ceca 30
HK - Hong Kong 26
NL - Olanda 26
IN - India 24
LT - Lituania 23
IR - Iran 18
AU - Australia 16
ES - Italia 12
JP - Giappone 11
KR - Corea 10
CH - Svizzera 8
IE - Irlanda 8
MX - Messico 8
RO - Romania 8
TW - Taiwan 7
TN - Tunisia 5
BG - Bulgaria 4
EG - Egitto 4
EU - Europa 4
NO - Norvegia 4
DK - Danimarca 3
GE - Georgia 3
MY - Malesia 3
VE - Venezuela 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AR - Argentina 2
BD - Bangladesh 2
CL - Cile 2
DZ - Algeria 2
GR - Grecia 2
IL - Israele 2
IQ - Iraq 2
LU - Lussemburgo 2
MD - Moldavia 2
PE - Perù 2
TH - Thailandia 2
TZ - Tanzania 2
ZA - Sudafrica 2
A1 - Anonimo 1
AT - Austria 1
AZ - Azerbaigian 1
CO - Colombia 1
EC - Ecuador 1
HN - Honduras 1
JO - Giordania 1
KE - Kenya 1
LI - Liechtenstein 1
MA - Marocco 1
MC - Monaco 1
MK - Macedonia 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
Totale 31.080
Salva come PNG Salva come JPEG
Città #
Fairfield 3.039
Woodbridge 2.826
Houston 1.729
Ashburn 1.446
Jacksonville 1.381
Ann Arbor 1.270
Chandler 1.231
Seattle 1.183
Cambridge 1.065
Wilmington 1.057
Santa Clara 1.012
Singapore 777
Warsaw 724
Izmir 488
Ferrara 431
Nanjing 388
Beijing 345
Princeton 311
Boardman 251
San Diego 240
Shanghai 156
Milan 140
Jakarta 137
New York 134
Shenyang 128
Nanchang 123
Dearborn 110
Los Angeles 108
Tianjin 76
Changsha 73
Hebei 70
Jiaxing 63
Dong Ket 62
Falls Church 61
Mountain View 60
Brussels 58
London 57
Bremen 55
Jinan 53
San Mateo 50
Norwalk 48
Kunming 46
Helsinki 45
Munich 45
Bologna 44
Zhengzhou 44
Auburn Hills 42
Toronto 39
Redwood City 38
Rome 37
Tappahannock 33
Orange 31
Frankfurt am Main 29
Ottawa 25
Guangzhou 24
Addison 23
Brno 22
Philadelphia 20
Washington 20
Hong Kong 19
Leawood 19
Ningbo 19
Verona 18
Augusta 17
Des Moines 17
Ferrara di Monte Baldo 17
Indiana 16
Sanayi 16
Scottsdale 16
Trieste 16
Changchun 15
Haikou 13
Hangzhou 13
Lappeenranta 13
Montréal 12
Ardabil 11
Kilburn 11
Redmond 11
Taizhou 11
Padova 10
Lanzhou 9
San Francisco 9
Genoa 8
Hefei 8
Hounslow 8
Chicago 7
Imola 7
Monmouth Junction 7
Naples 7
Parma 7
Wuhan 7
Andover 6
Bari 6
Dallas 6
Dronten 6
Falkenstein 6
Florence 6
Taipei 6
Forlì 5
Fuzhou 5
Totale 24.069
Salva come PNG Salva come JPEG
Nome #
Trattato di Anatomia Umana 244
Trattato di Anatomia Umana 239
Targeting mTOR in Acute Lymphoblastic Leukemia 213
PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell lines 201
Intranasal Administration of Recombinant TRAIL Down-Regulates CXCL-1/KC in an Ovalbumin-Induced Airway Inflammation Murine Model 190
MDM2/X inhibitors under clinical evaluation: Perspectives for the management of hematological malignancies and pediatric cancer 185
Targeting the phosphatidylinositol 3-kinase/Akt/mechanistic target of rapamycin signaling pathway in B-lineage acute lymphoblastic leukemia: An update 181
The anti-leukemic activity of sodium dichloroacetate in p53(mutated/null) cells is mediated by a p53-independent ILF3/p21 pathway 180
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model 180
Design, synthesis and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity 173
Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in Cognitive Impairment Diseases 172
The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells 170
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 170
Cytokine levels in the serum of healthy subjects 168
Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1 160
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 159
Impact of physical exercise in cancer survivors during and after antineoplastic treatments 159
Oxidative stress: role of physical exercise and antioxidant nutraceuticals in adulthood and aging 158
Cardiovascular disease-related miRNAs expression: Potential role as biomarkers and effects of training exercise 157
Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia 156
Changes of nuclear protein kinase C activity and isotype composition in PC12 cell proliferation and differentiation 155
Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia 152
Synergistic cytotoxic activity of recombinant TRAIL plus the non-genotoxic activator of the p53 pathway nutlin-3 in acute myeloid leukemia cells 151
Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia 151
The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias 149
HelixComplex snail mucus exhibits pro-survival, proliferative and pro-migration effects on mammalian fibroblasts 149
Multiple dye-doped NIR-emitting silica nanoparticles for both flow cytometry and in vivo imaging 148
The circulating levels of TRAIL are extremely low after delivery but rapidly recover in both mothers and newborns 145
Association of serum tumor necrosis factor-related apoptosis inducing ligand with body fat distribution as assessed by dual X-rays absorptiometry 140
An autocrine loop of HIV type-1 Tat protein responsible for the improved survival/proliferation capacity of permanently tat-transfected cells and required for optimal HIV-1 LTR transactivating activity 140
Antiangiogenic activity of the MDM2 antagonist nutlin-3 139
Multimodal near-infrared-emitting PluS Silica nanoparticles with fluorescent, photoacoustic, and photothermal capabilities 139
Stroma-derived factor 1alpha induces a selective inhibition of human erythroid development via the functional upregulation of Fas/CD95 ligand. 136
Physical training interventions for children and teenagers affected by acute lymphoblastic leukemia and related treatment impairments 136
Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-hodgkin's lymphoma xenografts 135
In vivo anti-lymphoma activity of an agonistic human recombinant anti-TRAIL-R2 minibody. 134
Proper design of silica nanoparticles combines high brightness, lack of cytotoxicity and efficient cell endocytosis 134
Nutlin-3 upregulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feed-back anti-apoptotic mechanism 132
Lovastatin dose-dependently potentiates the pro-inflammatory activity of lipopolysaccharide both in vitro and in vivo 132
Two-gene mutation in a single patient: Biochemical and functional analysis for a correct interpretation of exome results 132
Clinical perspectives of TRAIL: Insights into central nervous system disorders 131
Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease 131
The Sorafenib plus Nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of the FLT3 and p53 status 130
Nanoparticles Loaded with Nutlin-3 Display Cytotoxicity Towards p53(wild-type) JVM-2 But Not Towards p53(mutated) BJAB Leukemic Cells 130
Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes 129
TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release 129
Association of Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) with Central Adiposity and Low-Density Lipoprotein Cholesterol 129
In Vitro Characterization of Circulating Endothelial Progenitor Cells Isolated from Patients with Acute Coronary Syndrome 129
Serum Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Levels in Older Subjects with Dementia and Mild Cognitive Impairment 129
HIV-1 Tat protein down-regulates CREB transcription factor expression in PC12 neuronal cells through a phosphatidylinositol 3-kinase/AKT/cyclic nucleoside phosphodiesterase pathway 128
null 128
Association between thyroid hormones and TRAIL 128
Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adults 128
HIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cells 127
TRAIL and Ceruloplasmin Inverse Correlation as a Representative Crosstalk between Inflammation and Oxidative Stress 126
In vitro growth of human fetal CD34+ cells in the presence of various combinations of recombinant cytokines under serum-free culture conditions 125
Actively targeted nanocarriers for drug delivery to cancer cells 125
All-trans retinoic acid shows multiple effects on the survival, proliferation and differentiation of human fetal CD34+ haemopoietic progenitor cells. 124
TNF-related apoptosis inducing ligand in ocular cancers and ocular diabetic complications 123
Kinetic Profiles of Inflammatory Mediators in the Conjunctival Sac Fluid of Patients upon Photorefractive Keratectomy 123
A Brain Hidden in the Ferrara Cathedral: A Novel Interpretation of a Renaissance Masterpiece 123
Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets 123
The MDM-2 antagonist nutlin-3 promotes the maturation of acute myeloid leukemic blasts 122
Redox signaling and oxidative stress: Cross talk with TNF-related apoptosis inducing ligand activity 122
Circulating levels of TNF-related apoptosis inducing-ligand are decreased in patients with large adult-type granulosa cell tumors—implications for therapeutic potential 122
GM-CSF Exhibits Anti-Inflammatory Activity on Endothelial Cells Derived from Chronic Venous Disease Patients 121
The MDM2 inhibitor Nutlin-3 attenuates streptozotocin-induced diabetes mellitus and increases serum level of IL-12p40. 121
COVID-19 and individual genetic susceptibility/receptivity: Role of ACE1/ACE2 genes, immunity, inflammation and coagulation. might the double x-chromosome in females be protective against SARS-COV-2 compared to the single x-chromosome in males? 121
Role of CREB transcription factor in c-fos activation in natural killer cells. 120
Human Herpesvirus 7 infection induces profound cell cycle perturbations coupled to disregulation of cdc2 and cyclin B and polyploidization of CD4+ T Cells 120
TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells 120
Cell-based therapies for diabetic complications. 120
Conjunctival sac fluid contains elevated levels of soluble TRAIL: implications for the anti-tumoral surveillance of the anterior surface of the eye 120
Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells 119
Circulating levels of frizzled-related protein (FRZB) are increased in patients with early rheumatoid arthritis and decrease in response to disease-modifying antirheumatic drugs. 119
Molecular targets for selective killing of TRAIL-resistant leukemic cells. 119
Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL) 119
State of art and recent developments of anti-cancer strategies based on TRAIL 119
Inflammation and Cardiovascular Cross Talk in Ischemic Vascular Diseases 119
HIV-1 Tat induces tyrosine phosphorylation of p125FAK and its association with phosphoinositide 3-kinase in PC12 cells. 118
Pivotal role of cyclic nucleoside phosphodiesterase 4 in Tat-mediated CD4+ T cell hyperactivation and HIV type 1 replication 118
Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells 118
Low Circulating TRAIL Levels Are Associated with Increase of Resistin and Lipocalin-2/ngal Adipokines in Postmenopausal Women 118
Mesenchymal stem cells display hepato-protective activity in lymphoma bearing xenografts 117
Differential gene expression induction by TRAIL in B chronic lymphocytic leukemia (B-CLL) cells showing high versus low levels of Zap-70 116
Influence of physical exercise on microRNAs in skeletal muscle regeneration, aging and diseases 116
Roles and clinical implications of microRNAs in acute lymphoblastic leukemia 115
MDM2 antagonist Nutlin-3 suppresses the proliferation and differentiation of human pre-osteoclasts through a p53-dependent pathway 114
Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity 114
Nuclear translocation of protein kinase C-α and -ζ isoforms in HL-60 cells induced to differentiate along the granulocytic lineage by all-trans retinoic acid 114
Involvement of TRAIL/TRAIL-receptors in human intestinal cell differentiation 113
Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells 113
Circulating TRAIL shows a significant post-partum decline associated to stressful conditions. 113
JCV plus Patients with Inflammatory Bowel Disease show elevated plasma levels of MIG and SCF 113
Human herpesvirus type 7 in Hodgkin's disease 112
Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets. 112
TRAIL, a New Weapon against Neointimal Hyperplasia 112
The tumour necrosis factor-related apoptosis inducing ligand-osteoprotegerin system in limited systemic sclerosis: a new disease marker? 112
Cell cycle block by p53 activation reduces SARS-CoV-2 release in infected alveolar basal epithelial A549-hACE2 cells 111
Extracellular HIV-1 Tat protein activates phosphatidylinositol 3- and Akt/PKB kinases in CD4+ T lymphoblastoid Jurkat cells. 111
Totale 13.685
Salva come PNG Salva come JPEG
Categoria #
all - tutte 142.440
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.826
Totale 144.266
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.991 0 0 0 0 0 830 690 737 624 641 278 191
2020/20215.096 342 413 213 558 430 546 262 595 177 718 526 316
2021/20223.048 109 312 243 136 158 180 158 177 119 257 363 836
2022/20233.019 334 136 119 357 462 472 103 271 387 52 186 140
2023/20241.541 179 207 73 42 106 195 61 147 42 41 64 384
2024/20252.963 257 192 604 332 995 583 0 0 0 0 0 0
Totale 31.693